- Home
- EVTV vs KZIA Comparison
EVTV vs KZIA Comparison
Compare EVTV & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- KZIA
- Stock Information
- Founded
- EVTV 2012
- KZIA 1994
- Country
- EVTV United States
- KZIA Australia
- Employees
- EVTV N/A
- KZIA N/A
- Industry
- EVTV Auto Manufacturing
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- EVTV Consumer Discretionary
- KZIA Health Care
- Exchange
- EVTV Nasdaq
- KZIA Nasdaq
- Market Cap
- EVTV 5.4M
- KZIA 860.8K
- IPO Year
- EVTV 2017
- KZIA 1999
- Fundamental
- Price
- EVTV $0.25
- KZIA $3.26
- Analyst Decision
- EVTV
- KZIA Strong Buy
- Analyst Count
- EVTV 0
- KZIA 2
- Target Price
- EVTV N/A
- KZIA $57.50
- AVG Volume (30 Days)
- EVTV 113.1K
- KZIA 44.4K
- Earning Date
- EVTV 05-19-2025
- KZIA 05-16-2025
- Dividend Yield
- EVTV N/A
- KZIA N/A
- EPS Growth
- EVTV N/A
- KZIA N/A
- EPS
- EVTV N/A
- KZIA N/A
- Revenue
- EVTV $1,870,060.00
- KZIA $1,655,324.00
- Revenue This Year
- EVTV N/A
- KZIA N/A
- Revenue Next Year
- EVTV N/A
- KZIA N/A
- P/E Ratio
- EVTV N/A
- KZIA N/A
- Revenue Growth
- EVTV N/A
- KZIA 248000.00
- 52 Week Low
- EVTV $0.23
- KZIA $2.86
- 52 Week High
- EVTV $2.61
- KZIA $79.00
- Technical
- Relative Strength Index (RSI)
- EVTV 42.22
- KZIA 40.78
- Support Level
- EVTV $0.24
- KZIA $3.10
- Resistance Level
- EVTV $0.27
- KZIA $4.28
- Average True Range (ATR)
- EVTV 0.02
- KZIA 0.45
- MACD
- EVTV 0.00
- KZIA 0.02
- Stochastic Oscillator
- EVTV 31.51
- KZIA 26.09
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.